Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS
Zhijie Wu, Shouguo Gao, Qingyan Gao, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 8, pp. 101160-101160
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Shared and distinct mechanisms of UBA1 inactivation across different diseases
Jason C. Collins, Samuel J. Magaziner, Maya English, et al.
The EMBO Journal (2024) Vol. 43, Iss. 10, pp. 1919-1946
Open Access | Times Cited: 18
VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management
Matthew J. Koster, Terra L. Lasho, Horatiu Olteanu, et al.
American Journal of Hematology (2023) Vol. 99, Iss. 2, pp. 284-299
Closed Access | Times Cited: 32
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX
Jérôme Hadjadj, Yann Nguyen, Dalila Mouloudj, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 10, pp. 1358-1367
Closed Access | Times Cited: 16
VEXAS syndrome: An update
Mohamed-Yacine Khitri, Jérôme Hadjadj, A. Mékinian, et al.
Joint Bone Spine (2024) Vol. 91, Iss. 4, pp. 105700-105700
Closed Access | Times Cited: 10
JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib
Andrea Ceccardi, Martina Dameri, Francesco Ravera, et al.
British Journal of Haematology (2025)
Open Access | Times Cited: 1
Clonal hematopoiesis and autoimmunity
Ashwin Kishtagari, Robert W. Corty, Valeria Visconte
Seminars in Hematology (2024) Vol. 61, Iss. 1, pp. 3-8
Closed Access | Times Cited: 7
VEXAS syndrome
Hideaki Nakajima, Hiroyoshi Kunimoto
International Journal of Hematology (2024)
Open Access | Times Cited: 6
Single-cell genotype-phenotype mapping identifies therapeutic vulnerabilities in VEXAS syndrome
Saravanan Ganesan, Rebecca M. Murray, Jesús Alfonso López Sotélo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Proteome-wide Ligand and Target Discovery by Using Strain-Enabled Cyclopropane Electrophiles
Yue Liu, Zhongtang Yu, Peishan Li, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 30, pp. 20823-20836
Closed Access | Times Cited: 4
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome in a patient with subacute cutaneous lupus (SCLE)
Stephanie Tancer, Kyla R. Rodgers, Douglas Fullen, et al.
BMJ Case Reports (2025) Vol. 18, Iss. 1, pp. e261174-e261174
Closed Access
Aspects cliniques diagnostiques et thérapeutiques du syndrome VEXAS
Paul Breillat, Benjamin Terrier
Bulletin de l Académie Nationale de Médecine (2025)
Closed Access
VEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant management
Alessandro Nanni Costa, Federica Pilo, Martina Pettinau, et al.
Annals of Hematology (2025)
Open Access
VEXAS, Chediak–Higashi syndrome and Danon disease: myeloid cell endo-lysosomal pathway dysfunction as a common denominator?
Coline Savy, Maxence Bourgoin, Thomas Cluzeau, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access
Altered IgG4 serum levels in VEXAS syndrome – a retrospective monocentric cohort study
Sebastian Saur, Benedikt Obermaier, Reinhild Klein, et al.
Rheumatology International (2025) Vol. 45, Iss. 4
Open Access
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome
Raffaella Molteni, Martina Fiumara, Corrado Campochiaro, et al.
Nature Medicine (2025)
Open Access
VEXAS syndrome: A newly identified X-Linked hematoinflammatory disorder – A comprehensive overview of its genetic, molecular, inflammatory, and clinical landscape
Alpana Singh, Rishabh Chaudhary
Journal of Autoimmunity (2025) Vol. 154, pp. 103425-103425
Closed Access
Neutrophilic Urticarial Dermatosis: A Window into Systemic Inflammation and Autoimmune Disorders
Xiaoxuan Cai, Yadan Zheng, Changyi Yang, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
The pathogenesis, clinical presentations and treatment of monogenic systemic vasculitis
Ahmet Gül, Ivona Aksentijevich, Paul Brogan, et al.
Nature Reviews Rheumatology (2025)
Closed Access
Unraveling immunosenescence in sepsis: from cellular mechanisms to therapeutics
Yanghanzhao Wang, Hao Zhang, Changhong Miao
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Somatic mutations in autoinflammatory and autoimmune disease
Sofia Torreggiani, Flore S. Castellan, Ivona Aksentijevich, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 11, pp. 683-698
Closed Access | Times Cited: 3
VEXAS Syndrome: A Comprehensive Review of Current Therapeutic Strategies and Emerging Treatments
Safi Alqatari, Abdulaziz A. Alqunais, Shahad Mufeed Alali, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6970-6970
Open Access | Times Cited: 3
VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic): clinical review in a rapidly emerging field
Luan Phan, Danielle Hammond, Nathaniel R. Wilson, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 9, pp. 1245-1257
Closed Access | Times Cited: 2
The role of 18FDG–PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature
Riccardo Bixio, Sara Bindoli, Andrea Morciano, et al.
Internal and Emergency Medicine (2024)
Open Access | Times Cited: 2
Cellular models in autoinflammatory disease research
Başak Şen, Banu Balcı‐Peynircioğlu
Clinical & Translational Immunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Clonal cytopenia of undetermined significance: definitions, risk and therapeutic targets
Cristian C. Taborda, Amer M. Zeidan, Lourdes M. Mendez
Frontiers in Hematology (2024) Vol. 3
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top